share_log

JMP Securities Maintains Market Outperform on Bicycle Therapeutics, Lowers Price Target to $32

JMP Securities Maintains Market Outperform on Bicycle Therapeutics, Lowers Price Target to $32

JMP Securities維持自行車療法的市場跑贏大盤,將目標股價下調至32美元
Benzinga ·  2023/12/20 07:06

JMP Securities analyst Reni Benjamin maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Market Outperform and lowers the price target from $44 to $32.

JMP證券分析師雷尼·本傑明維持Bicycle Therapeutics(納斯達克股票代碼:BCYC)的市場表現跑贏大盤,並將目標股價從44美元下調至32美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論